Frontiers  Lu-177-PSMA dosimetry for kidneys and tumors based on

Frontiers Lu-177-PSMA dosimetry for kidneys and tumors based on

4.7
(311)
Write Review
More
$ 21.00
Add to Cart
In stock
Description

EAU 2022: Discussion: LuTectomy – A Single-arm Study of the

Radiation Dosimetry in 177Lu-PSMA-617 Therapy - ScienceDirect

Intra-therapeutic dosimetry of [177Lu]Lu-PSMA-617 in low-volume

Hotspots and frontiers in PSMA research for prostate cancer: a

PDF) Influence of dosimetry method on bone lesion absorbed dose

PDF) Lu-177-PSMA dosimetry for kidneys and tumors based on SPECT

Investigation of image-based lesion and kidney dosimetry protocols

Feasibility of single time point image-based dosimetry using prior

Intra-therapeutic dosimetry of [177Lu]Lu-PSMA-617 in low-volume

SNMMI 2023: Tumour-to-Kidney Ratio on Pre-Therapeutic PSMA-PET-CT

Frontiers Lu-177-PSMA dosimetry for kidneys and tumors based on

Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy

Tumor and organ dosimetry from sequential quantitative SPECT/CT

177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration